|
Volumn 69, Issue 2, 2001, Pages 681-686
|
Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus ankara prime-boost vaccination regimen for murine tuberculosis
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIAL ANTIGEN;
BACTERIAL VACCINE;
DNA VACCINE;
EARLY SECRETORY ANTIGENIC TARGET 6;
GAMMA INTERFERON;
MYCOBACTERIAL PROTEIN TUBERCULOSIS 63;
PLASMID DNA;
RECOMBINANT VACCINE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BACTERIAL COUNT;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
IMMUNOGENICITY;
MOUSE;
MYCOBACTERIUM BOVIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TUBERCULOSIS;
VACCINIA VIRUS;
VIRUS RECOMBINANT;
VIRUS STRAIN;
|
EID: 0035141937
PISSN: 00199567
EISSN: None
Source Type: Journal
DOI: 10.1128/IAI.69.2.681-686.2001 Document Type: Article |
Times cited : (210)
|
References (23)
|